| abstract |
The present invention provides a combination of a hypoglycemic, metformin, and an irreversible inhibitor of gastric and pancreatic lipases in the intestine, orlistat, for better control of obesity than with the use of monotherapy with each of them; said composition provides "low" doses of both drugs to minimize side effects and take advantage of the synergistic effect of both compounds. |